Schoenherr has established a new Healthcare & Life Sciences group to provide more comprehensive advice to clients active in the healthcare sector. Florian Kusznier, corporate/m&a partner and Andreas Natterer, dispute resolution partner and President of the European Food Law Association, will jointly lead the team, building on many years of expertise in this field.
The healthcare sector is strongly regulated, but at the same time has a high degree of potential for innovation, which makes it interesting for technological development and investment. Legal advice in this field requires in-depth expertise and experience to deliver high-quality solutions tailored to the specificities of the industry. In Austria and the CEE region, Schoenherr has been successfully advising representatives from the healthcare, life sciences, biotech and pharmaceutical sectors for many years, from individual physicians to international corporations. Most recently, Schoenherr advised Roche on the acquisition of the diabetes app developer mySugr.
“Clients from the healthcare sector benefit from thorough industry and product-specific knowledge from various practice areas. Moreover, with its network of international offices, Schoenherr offers excellent geographical coverage for the growing healthcare sector,” explained Schoenherr Partner Florian Kusznier.
“A particular focus of our activities is on regulatory pharmaceutical and food law, where we are already one of the leading law firms in Austria. Our aim is to broaden our comprehensive expertise and to further improve the overall advice we provide to clients in the healthcare sector,” added partner Andreas Natterer.
The advisory range of the new Healthcare & Life Sciences group includes pharmaceuticals, medical devices, food, nutritional supplements and animal feed, genetic engineering and chemicals, as well as advice to physicians, other medical professions, nursing and care homes, hospitals and their operators, as well as investors in the health sector.
The team of experts
Schoenherr partners Florian Kusznier and Andreas Natterer lead the interdisciplinary team, which is complemented by experts from other practice areas such as Corporate Investigations & Crisis Management, NewTech, EU & Competition, Regulatory, and IP & IT.